[A case of the esophageal candidiasis supposedly caused by rhinenchysis steroid chronic administration before sleep].
In general, steroid is mainly used as anti-inflammatory action in case of allergic diseases. As one of the side effects of inhalation steroid, a report is given below regarding buccal capsule/esophageal candidiasis. The patient came to the hospital with the chief complaint regarding passage dysphagia in the time of deglutition; pharyngitis and esophageal candidiasis were found by endoscopy of upper gastrointestinal tract.The interview after the endoscopy revealed that the patient, a 69-year-old female was diagnosed as chronic perennial allergic rhinitis a few years ago, and had been inhaling rhinenchysis Beclometasone dipropionate (BDP) before sleep every day for the past two years because using this collunarium seemed to mitigate the nasal obstruction and mucus during sleep. The patient did not report this fact before the endocsopy because she did not associate it with her subjective symptom. In this case, it was assumed that nebulized rhinenchysis BDP was accidentally swallowed to the pharynx and esophagus during sleep. As a treatment, rhinenchysis BDP was canceled and instead Azunol mouth washing (gargling/nasal douche) was used. No antifungal agent was used. In two weeks, the patient reported some improvement, and this was confirmed by reexamination of the upper gastrointestinal tract using endoscope in one month and a half. Pharyngitis was improved, and in the digital endoscopic assessment of esophageal candidiasis complicating inhaled steroid therapy the esophageal candidiasis became Grade I (mild grade). As for the later progress, the patient did not report any subjective symptoms such as nasal obstruction and dysphagia. In addition, the inflammation caused by candidiasis and found in the early examination was improved. The patient in this case was under treatment for thrombosis in the vein of lower extremity, but no complications such as diabetes mellitus or immune deficiency syndrome were observed.


CONCLUSIONS
Esophageal candidiasis by chronic administration of inhalation of steroid before sleep for asthmatic patients has been reported. However, there has not been a report of esophageal candidiasis by chronic administration of rhinenchysis steroid before sleep for patients with allergic rhinitis. Similarly, in the case of the use of steroid in the form of collunarium before sleep, steroid stayed in the esophagus via the transendothelial nasal cavity, and that seemed to cause, in the long run, to develop esophageal candidiasis.


CONCLUSIONS
One of the implications of the above case is that collunarium can go down, even when it is nebulized in the nasal cavity, to the esophagus via the nasal cavity to buccal capsule. This suggests the necessity for preventative measures in the case of chronic administration of steroid as follows. A. Blowing of the nose just after the use of collunarium B. Daily rinsing (gargling and nasal douche).
Shuto
Hiroshi
H
Kenshinkai Medical Corporation Ekibiru Clinic of Sengendai Station.
Noguchi
Hisashi
H
Nishikata
Hikaru
H
Takizawa
Kenji
K
Shuto
Chizuru
C
Nagata
Makoto
M
Terashi
Yoshinori
Y
Yamaguchi
Michiya
M
Takizawa
Takao
T
Watanabe
Kensuke
K
Tosaka
Kaoru
K
Okano
Masahiko
M
Koizumi
Akira
A
D000280:Administration, Inhalation; D000368:Aged; D001507:Beclomethasone / Q000009:adverse effects*; D002177:Candidiasis / Q000139:chemically induced*; D004935:Esophageal Diseases / Q000139:chemically induced*; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D015508:Nasal Obstruction / Q000188:drug therapy; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D012890:Sleep; D013995:Time
D005938:Glucocorticoids; D001507:Beclomethasone